Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP Docetaxel + S-1 for Gastric Cancer with Malignant Ascites
NCT02779608Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in gastric cancer (GC), sponsored by Fudan University. Status: unknown.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02779608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779608.